{"id":42727,"date":"2016-06-24T13:05:35","date_gmt":"2016-06-24T17:35:35","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=42727"},"modified":"2016-06-24T19:56:43","modified_gmt":"2016-06-25T00:26:43","slug":"outcomes-following-management-of-squamous-cell-carcinoma-of-the-scalp-a-retrospective-series-of-235-patients-treated-at-the-peter-maccallum-cancer-centre","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/42727","title":{"rendered":"Outcomes following management of squamous cell carcinoma of the scalp: A retrospective series of 235 patients treated at the Peter MacCallum Cancer Centre"},"content":{"rendered":"<p><!--more--><\/p>\n<p>Australas J Dermatol. 2016 Jun 10. doi: 10.1111\/ajd.12520.<\/p>\n<p>Outcomes following management of squamous cell carcinoma of the scalp: A retrospective series of 235 patients treated at the Peter MacCallum Cancer Centre.<\/p>\n<p>Estall V1,2, Allen A3, Webb A4, Bressel M4, McCormack C4, Spillane J2,4.<\/p>\n<p><strong>Abstract<\/strong><\/p>\n<p><strong>BACKGROUND:<\/strong><\/p>\n<p>Squamous cell carcinoma of the scalp is a common clinical problem in an aging population. Despite its high incidence, little has been documented regarding treatment or outcomes.<\/p>\n<p><strong>METHODS:<\/strong><\/p>\n<p>We retrospectively analysed 235 cases treated with curative intent at Peter MaCallum Cancer Centre between 1998 and 2010. The cohort was analysed for its characteristics, management, survival and prognostic factors.<\/p>\n<p><strong>RESULTS:<\/strong><\/p>\n<p>The patients were primarily male (88%) with a median age of 79 years (range 53-98 years). There was a high proportion of immunosuppressed patients (29%) and stage T2 (48%) tumours. Management included surgery (45%), radiotherapy (28%) and surgery and adjuvant radiotherapy (26%). Median follow up from treatment was 4.5 years. Estimated 5-year overall survival (OS), disease-specific survival and progression-free survival (PFS) were 59, 94 and 51%, respectively. The 5-year cumulative incidence of local and regional relapse was 11 and 7%, respectively. There were four patients who developed distant metastases and died of their disease. Statistically significant prognostic factors identified for poor outcomes for OS and PFS were T2 stage (hazard ratio [1.7 and 2.1) and immunosuppression (HR 3.3 and 3.4).<\/p>\n<p><strong>CONCLUSIONS:<\/strong><\/p>\n<p>We conclude the presence of immunosuppression and T2 stage is prognostic for survival. Further research to establish treatment principles is warranted.<\/p>\n<p><strong>KEYWORDS:<\/strong><\/p>\n<p>cutaneous squamous cell carcinoma; immunosuppression; outcomes; scalp<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-42727","post","type-post","status-publish","format-standard","","category-articulos-cientificos"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/42727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=42727"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/42727\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=42727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=42727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=42727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}